These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19711206)

  • 1. Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
    Spector E; Franklin MJ; Truskinovsky AM; Dudek AZ
    Acta Oncol; 2010; 49(1):104-6. PubMed ID: 19711206
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient partial response to sorafenib treatment in an adolescent patient with MEN2B syndrome and end-stage medullary thyroid carcinoma.
    Aller S; Popescu A; Rao S; Morgan E; Gosiengfiao Y
    Pediatr Blood Cancer; 2012 Jan; 58(1):98-100. PubMed ID: 21721105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
    Procopio G; Verzoni E; Gevorgyan A; Mancin M; Pusceddu S; Catena L; Platania M; Guadalupi V; Martinetti A; Bajetta E
    Oncology; 2007; 73(3-4):204-9. PubMed ID: 18418013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma.
    Diamantis ML; Chon SY
    J Drugs Dermatol; 2010 Feb; 9(2):169-71. PubMed ID: 20214183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib in metastatic thyroid cancer.
    Capdevila J; Iglesias L; Halperin I; Segura A; Martínez-Trufero J; Vaz MÁ; Corral J; Obiols G; Grande E; Grau JJ; Tabernero J
    Endocr Relat Cancer; 2012 Apr; 19(2):209-16. PubMed ID: 22285864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid response to sorafenib in metastatic medullary thyroid carcinoma.
    Frank-Raue K; Ganten M; Kreissl MC; Raue F
    Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):151-5. PubMed ID: 20827665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-standing differentiated thyroid carcinoma].
    Cabrejas Gómez Mdel C; Aguillo Gutiérrez E; Altemir Trallero J; Ocón Bretón J; Lázaro Sierra J
    Endocrinol Nutr; 2012 Jan; 59(1):78-81. PubMed ID: 21835705
    [No Abstract]   [Full Text] [Related]  

  • 8. Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect.
    Lopez V; Pinazo I; Marti N; Monteagudo C; Jorda E
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):959-60. PubMed ID: 18785888
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
    Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
    Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cutaneous metastatic chordomas from the sacrum.
    Svoboda RM; Mackay D; Welsch MJ; Anderson BE
    J Am Acad Dermatol; 2012 Jun; 66(6):e246-7. PubMed ID: 22583730
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
    Blumenschein GR; Gatzemeier U; Fossella F; Stewart DJ; Cupit L; Cihon F; O'Leary J; Reck M
    J Clin Oncol; 2009 Sep; 27(26):4274-80. PubMed ID: 19652055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
    Ravaud A; de la Fouchardière C; Caron P; Doussau A; Do Cao C; Asselineau J; Rodien P; Pouessel D; Nicolli-Sire P; Klein M; Bournaud-Salinas C; Wemeau JL; Gimbert A; Picat MQ; Pedenon D; Digue L; Daste A; Catargi B; Delord JP
    Eur J Cancer; 2017 May; 76():110-117. PubMed ID: 28301826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib: delivering a targeted drug to the right targets.
    Flaherty KT
    Expert Rev Anticancer Ther; 2007 May; 7(5):617-26. PubMed ID: 17492926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer.
    Bianchi G; Loibl S; Zamagni C; Salvagni S; Raab G; Siena S; Laferriere N; Peña C; Lathia C; Bergamini L; Gianni L
    Anticancer Drugs; 2009 Aug; 20(7):616-24. PubMed ID: 19739318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma.
    Elser C; Siu LL; Winquist E; Agulnik M; Pond GR; Chin SF; Francis P; Cheiken R; Elting J; McNabola A; Wilkie D; Petrenciuc O; Chen EX
    J Clin Oncol; 2007 Aug; 25(24):3766-73. PubMed ID: 17704426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors.
    Strumberg D; Clark JW; Awada A; Moore MJ; Richly H; Hendlisz A; Hirte HW; Eder JP; Lenz HJ; Schwartz B
    Oncologist; 2007 Apr; 12(4):426-37. PubMed ID: 17470685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Painful leg mass.
    Lucas LM
    J Fam Pract; 2012 May; 61(5):287-90. PubMed ID: 22577632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Resistant Clones in Medullary Thyroid Cancer May Not Be Rescued by Subsequent Salvage Highly Selective Rearranged During Transfection-Inhibitor Therapy.
    Bruce JY; Bible KC; Chintakuntlawar AV
    Thyroid; 2021 Feb; 31(2):332-333. PubMed ID: 32664802
    [No Abstract]   [Full Text] [Related]  

  • 19. Sorafenib: tolerance in patients on chronic hemodialysis: a single-center experience.
    Rey PM; Villavicencio H
    Oncology; 2008; 74(3-4):245-6. PubMed ID: 18716419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous metastases of prostatic small cell neuroendocrine carcinoma.
    Nakamura Y; Kashiwagi K; Nakamura A; Muto M
    Eur J Dermatol; 2014; 24(5):620-2. PubMed ID: 25075810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.